Results for this period
Interim period (second quarter)1 January 2026–30 June 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The number of placement assignments and completed contracts increased as a result of the reorganisation and review of the sales structure for the full-time physician placement service. The Company withdrew from non-core businesses and allocated human and financial resources with a focus on its healthcare platform business.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 June 2026 |
| Net Sales | ¥2,126 million (YoY +1.0%) |
| Operating profit | ¥171 million (YoY +12.5%) |
| Ordinary income | ¥178 million (YoY +20.2%) |
| Profit attributable to owners of the parent | ¥100 million (YoY +33.9%) |
| Net income per share | ¥18.37 |
| Equity ratio | End of the current fiscal period 74.6 / End of previous period 71.7 |
| Total assets | ¥6,367 million |
| Net assets | ¥4,745 million |
| Cash flows from operating activities | ¥220,068 thousand |
| Cash flows from investing activities | ¥-152,505 thousand |
| Cash flows from financing activities | ¥-205,503 thousand |
| Cash and cash equivalents at end of period | ¥1,533,991 thousand |
| Full-year earnings forecast | Net Sales ¥3,950 million (YoY +3.2%) / Operating profit ¥195 million (YoY +165.1%) / Ordinary income ¥200 million (YoY +132.0%) / Net income ¥125 million (YoY +149.9%) |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Depreciation and amortization | 114,725 Thousands of yen (depreciation and amortization) |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 1 company (株式会社医師たちとつくる) |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No (for institutional investors and securities analysts) |
| Issued Shares at Period-End | 5,718,600 Shares |
| Treasury Shares at Period-End | 245,389 Shares |
| Factors Behind Changes in Business Performance | The number of placement assignments and completed contracts increased as a result of the reorganisation and review of the sales structure for the full-time physician placement service. The Company withdrew from non-core businesses and allocated human and financial resources with a focus on its healthcare platform business. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The reorganisation and review of the sales structure for the full-time physician placement service began to bear fruit, resulting in increases in the number of placement assignments and completed contracts. The Company also sold a non-core business and concentrated management resources on its healthcare platform business.